Enhanced thrombin generation in children with sickle cell disease

Area of Science:

• Hematology
• Pediatric Medicine
• Thrombosis Research

Background:

• Sickle cell disease (SCD) is an inherited blood disorder with significant childhood morbidity.
• Vascular occlusion in SCD may involve increased coagulation system activity.
• Previous studies on coagulation in SCD primarily focused on adult populations.

Purpose of the Study:

• To investigate coagulation system activity in children with sickle cell disease.
• To assess markers of thrombin generation and coagulation inhibitors in pediatric SCD patients.

Main Methods:

• Prospective study comparing 16 homozygous SCD patients with 16 age-matched controls.
• Measurement of prothrombin fragment F1+2 and thrombin-antithrombin III (TAT) complexes.
• Assessment of protein C activity, total and free protein S, and antithrombin III (AT III) levels.

Main Results:

• SCD patients exhibited significantly elevated plasma concentrations of F1+2 and TAT complexes.
• Significantly reduced levels of protein C activity and total/free protein S were observed in SCD patients.
• Plasma AT III levels did not differ between SCD patients and controls.

Conclusions:

• Children with SCD demonstrate evidence of enhanced thrombin generation.
• Reduced levels of protein C and protein S may contribute to the observed hypercoagulable state in pediatric SCD.
• Further research is needed to establish the clinical significance of this coagulation imbalance in childhood SCD.